eXmoor pharma, the end-to-end cell and gene therapy (CGT) manufacturing partner, today announced the close of a USD 35 million Series A financing round, from new investor Kineticos Ventures and existing investor MVM Partners. The funding will help launch eXmoor’s Cell and Gene Therapy Centre, a 65,000 sq ft GMP .
/PRNewswire/ Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million.
Inceptor Bio Launches Advanced Manufacturing Platform to Treat Cancers | North Carolina Biotechnology Center ncbiotech.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncbiotech.org Daily Mail and Mail on Sunday newspapers.